Polysialic acid bioengineering of cancer and neuronal cells by N-acyl sialic acid precursor treatment

Advances in Experimental Medicine and Biology

Volumn 705, Issue , 2011, Pages 679-688

  Pon, Robert A ^b   Zou, Wei ^b   Jennings, Harold J ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b NONE

Author keywords

Bioengineering; Cancer; Ganglioside; Polysialic acid; Sialic acid

Indexed keywords

ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; MANNOSAMINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 13D9; MONOCLONAL ANTIBODY 2A; N ACYL SIALIC ACID; N BUTANOYL MANNOSAMINE; N PROPIONYL MANNOSAMINE; POLYSIALIC ACID; SIALIC ACID; UNCLASSIFIED DRUG; HEXOSAMINE; N BUTANOYLMANNOSAMINE; N PROPIONYLMANNOSAMINE; N-BUTANOYLMANNOSAMINE; N-PROPIONYLMANNOSAMINE; PRODRUG; SIALIC ACID DERIVATIVE;

BIOENGINEERING; BIOSYNTHESIS; CANCER CELL; CANCER CELL CULTURE; CANCER CONTROL; CANCER INHIBITION; CANCER LOCALIZATION; CELL ASSAY; CELL SURFACE; CONFERENCE PAPER; DISEASE MARKER; FLOW CYTOMETRY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NEPHROBLASTOMA; NERVE CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; TISSUE DISTRIBUTION; VALIDATION PROCESS; ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY SPECIFICITY; ARTICLE; CANCER TRANSPLANTATION; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LEUKEMIA; MELANOMA; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE ENGINEERING; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; HEXOSAMINES; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKEMIA; MELANOMA; MICE; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NEURONS; PRODRUGS; SIALIC ACIDS; TISSUE ENGINEERING;

EID: 80054023219     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7877-6_36     Document Type: Conference Paper

References (30)

1. Szele FG, Dowling JJ, Gonzales C, Theveniau M, Rougon G, Chesselet MF (1994) Pattern of expression of highly polysialylated neural cell adhesion molecule in the developing and adult rat striatum. Neuroscience 60:133-144
2. Theodosis DT, Rougon G, Poulain DA (1991) Retention of embryonic features by an adult neuronal system capable of plasticity: polysialylated neural cell adhesion molecule in the hypothalamo-neurohypo-physial system. Proc Natl Acad Sci USA 88:5494-5498
3. Troy FA (1992) Polysialylation: from bacteria to brains. Glycobiology 2:5-23
4. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E (1998) Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 22:1267-1276
5. Rutishauser U (1996) Polysialic acid and the regulation of cell interactions. Curr Opin Cell Biol 8:679-684
6. Petridis AK, El Maarouf A, Rutishauser U (2004) Polysialic acid regulates cell contact-dependent neuronal differentiation of progenitor cells from the subventricular zone. Dev Dyn 230:675-684
7. El Maarouf A, Rutishauser U (2003) Removal of polysialic acid induces aberrant pathways, synaptic vesicle distribution, and terminal arborization of retinotectal axons. J Comp Neurol 460:203-211
8. Rutishauser U, Landmesser L (1996) Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci 19:422-427
9. Roth J, Zuber C, Wagner P, Taatjes DJ, Weisgerber C, Heitz PU, Goridis C, Bitter-Suermann D (1988) Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci USA 85:2999-3003
10. Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Inui K, Oyanagi H, Yamada T, Nakayama J, Fujimoto I, Ikenaka K, Wada H (2001) Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. Cancer Res 26:1666-1670
11. Komminoth P, Roth J, Lackie PM, Bitter-Suermann D, Heitz PU (1991) Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 26:297-304
12. Livingston BD, Jacobs JL, Glick MC, Troy FA (1988) Extended polysialic acid chains (n greater than 55) in glycoproteins from human neuroblastoma cells. J Biol Chem 26326:9443-9448
13. Soler AP, Johnson KR, Wheelock MJ, Knudsen KA (1993) Rhabdomyosarcoma- derived cell lines exhibit aberrant expression of the cell-cell adhesion molecules N-CAM, N-cadherin, and cadherin-associated proteins. Exp Cell Res 208:84-93
14. Scheidegger EP, Lackie PM, Papay J, Roth J (1994) In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab Invest 70:95-106
15. Daniel L, Durbec P, Gautherot E, Rouvier E, Rougon G, Figarella-Branger D (2001) A nude mice model of human rhabdomyosarcoma lung metastases for evaluating the role of polysialic acids in the metastatic process. Oncogene 20:997-1004
16. Cheung IY, Vickers A, Cheung NK (2006) Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma. Int J Cancer 119:152-156
17. Keppler OT, Horstkorte R, Pawlita M, Schmidt C, Reutter W (2001) Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 11:11R-18R
18. Mahal LK, Yarema KJ, Bertozzi CR (1997) Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 276:1125-1128
19. Liu T, Guo Z, Yang Q, Sad S, Jennings HJ (2000) Biochemical engineering of surface alpha 2-8 polysialic acid for immunotargeting tumor cells. J Biol Chem 275:32832-32836
20. Krug LM, Ragupathi G, Ng KK, Hood C, Jennings HJ, Guo Z, Kris MG, Miller V, Pizzo B, Tyson L, Baez V, Livingston PO (2004) Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin. Clin Cancer Res 10:916-923
21. Frosch M, Gorgen I, Boulnois GJ, Timmis KN, Bitter-Suermann D (1985) NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the poly-saccharide capsules of Escherichia coli K1 and group B meningococci. Proc Natl Acad Sci USA 82:1194-1198
22. Zou W, Borrelli S, Gilbert M, Liu T, Pon RA, Jennings HJ (2004) Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells. J Biol Chem 279:25390-25399
23. Livingston PO, Hood C, Krug LM, Warren N, Kris MG, Brezicka T, Ragupathi G (2005) Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy. Cancer Immunol Immunother 54:1018-1025
24. Charter NW, Mahal LK, Koshland DE, Bertozzi CR (2000) Biosynthetic incorporation of unnatural sialic acids into polysialic acid on neural cells. Glycobiology 10:1049-1056
25. Mahal LK, Charter NW, Angata K, Fukuda M, Koshland DEJ, Bertozzi CR (2001) A small-molecule modulator of poly-alpha 2, 8-sialic acid expression on cultured neurons and tumor cells. Science 294:380-381
26. Horstkorte R, Muhlenhoff M, Reutter W, Nohring S, Zimmermann-Kordmann M, Gerardy-Schahn R (2004) Selective inhibition of polysialyltransferase ST8SiaII by unnatural sialic acids. Exp Cell Res 298:268-274
27. Pon RA, Biggs NJ, Jennings HJ (2007) Polysialic acid bioengineering of neuronal cells by N-acyl sialic acid precursor treatment. Glycobiology 17:249-260
28. Jennings HJ (2003) Polysialic acid vaccines. In: Wong C (ed) Carbohydrate-based drug discovery. Wiley, Weinham, pp 357-380
29. MacKenzie CR, Jennings HJ (2003) Characterization of polysaccharide conformational epitopes by surface plasmon resonance. Methods Enzymol 363:340-354
30. Bruses JL, Rutishauser U (2001) Roles, regulation, and mechanism of polysialic acid function during neural development. Biochimie 83:635-643